advancing innovation to save lives

The Hill features op-ed from GHTC director

The Hill featured an op-ed from GHTC Director Jamie Bay Nishi which highlights the historic decline in US government investment in neglected disease R&D and calls for the US to increase funding and reassert American leadership in global health innovation.

Pipeline of Promise

Learn about the global health R&D process through our interactive Pipeline of Promise infographic.
Learn More

International Partnership For Microbicides

The International Partnerships for Microbicides (IPM) is a nonprofit organization that developed the monthly dapivirine ring, and is dedicated to accelerating the development and availability of other new HIV prevention tools for women in developing countries.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Doune Porter
GHTC calls for US engagement in innovative effort to bring vaccines to children worldwide

GlaxoSmithKline and Pfizer today announced that they have joined the first Advance Market Commitment (AMC), a unique funding effort to bring pneumococcal vaccines to millions of children worldwide. GHTC commends increased involvement in the AMC and calls on the United States to participate in innovative health financing mechanisms, including a future AMC, to maximize the life-saving potential of immunizations worldwide.

Learn More
PATH/Patrick McKern
GHTC applauds CSIS Commission report highlighting need for global health research, innovative financing

The Center for Strategic and International Studies (CSIS) today released the final report of its Commission on Smart Global Health Policy, providing recommendations for US policymakers on creating a long-term and strategic approach to global health. GHTC applauds the Commission’s inclusion of research and innovative financing among its recommendations for strengthening US global health programs, developing new products, and bolstering health systems overseas.

Learn More
View All News & Events

Community Event

McGill University
McGill Summer Institute in Infectious Diseases and Global Health
McGill University
Learn More
View All Events
Photo: White house/Shealah Craighead
Medical research, global health programs face steep cuts in Trump budget

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

Read More
CDC/Dr. Scott Smith
G20 health ministers pledge support for R&D to combat antimicrobial resistance, pandemic threats

Health ministers from G20 nations, meeting for the first time, pledged to work together to combat antimicrobial resistance and improve pandemic preparedness, emphasizing the critical role research and development plays in confronting these global challenges.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide